Aytu BioScience Inc (AYTU) USD0.0001
Sell:$1.21Buy:$1.28
$0.05
(3.94%)
- This stock can be held in a
Stocks and Shares ISA$0.05
(3.94%)$0.05
(3.94%)Company Information
About this company
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Key people
Key facts
- EPICAYTU
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS0547548588
- Market cap$7.77m
- Employees99
- Shares in issue6.17m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.